Viewing StudyNCT03034967



Ignite Creation Date: 2024-05-06 @ 9:37 AM
Last Modification Date: 2024-10-26 @ 12:17 PM
Study NCT ID: NCT03034967
Status: COMPLETED
Last Update Posted: 2020-10-28
First Post: 2017-01-25

Brief Title: Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease COPD
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Pulmonary Disease Chronic Obstructive
Keywords:
Name View
HCRU exacerbations View
SGRQ View
CXCR2 antagonist View
GSK1325756 View
Danirixin View
COPD View